Preoperative inhibition of cyclooxygenase-1 in the spinal cord reduces postoperative pain

Anesthesia and Analgesia

Volumn 100, Issue 5, 2005, Pages 1390-1393

  Zhu, Xiaoying ^a   Conklin, Dawn R ^a   Eisenach, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; HALOTHANE; KETOROLAC; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; MECHANICAL STIMULATION; NONHUMAN; POSTOPERATIVE PAIN; PREOPERATIVE CARE; PRIORITY JOURNAL; RAT; SENSITIZATION; SPINAL CORD; SURGICAL APPROACH;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; KETOROLAC; MALE; MEMBRANE PROTEINS; PAIN, POSTOPERATIVE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 17744400538     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000148127.53832.8E     Document Type: Article

References (25)

1. O'Banion MK. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999;13:45-82.
2. Ebersberger A, Grubb BD, Willingale HL, et al. The intraspinal release of prostaglandin E2 in a model of acute arthritis is accompanied by an up-regulation of cyclo-oxygenase-2 in the spinal cord. Neuroscience 1999,93:775-81.
3. Willingale HL, Gardiner NJ, McLymont N, et al. Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br J Pharmacol 1997;122:1593-604.
4. Zhu XY, Conklin D, Eisenach JC. Cyclooxygenase-1 in the spinal cord plays an important role in postoperative pain. Pain 2003;104:15-23.
5. Hay CH, Trevethick MA, Wheeldon A, et al. The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neuroscience 1997;78:843-50.
6. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410:471-5.
7. Beiche F, Brune K, Geisslinger G, Goppelt-Struebe M. Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm Res 1998;47:482-7.
8. Dirig DM, Isakson PC, Yaksh TL. Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther 1998;285:1031-8.
9. Yaksh TL, Dirig DM, Conway CM, et al. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX- 1. J Neurosci 2001;21:5847-53.
10. Yamamoto T, Nozaki-Taguchi N. Role of spinal cyclooxygenase (COX)-2 on thermal hyperalgesia evoked by carrageenan injection in the rat. Neuroreport 1997;8:2179-82.
11. Yamamoto T, Sakashita Y. The role of the spinal opioid receptor likel receptor, the NK-1 receptor, and cyclooxygenase-2 in maintaining postoperative pain in the rat. Anesth Analg 1999;89:1203-8.
12. Beltrutti D, Niv D, Ben Abraham R, et al. Late antinociception and lower untoward effects of concomitant intrathecal morphine and intravenous buprenorphine in humans. J Clin Anesth 2002;14:441-6.
13. Wordliczek J, Szczepanik AM, Banach M, et al. The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci 2000;66:1155-64.
14. Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics. Science 1976;192:1357-8.
15. Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain 1996;64:493-501.
16. Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63.
17. Yamamoto T, Sakashita Y. COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPA. Neuroreport 1998;9:3869-73.
18. Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999;96:7563-8.
19. Morrison BW, Christensen S, Yuan W, et al. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial. Clin Ther 1999;21:943-53.
20. Whiteside GT, Harrison J, Boulet J, et al. Pharmacological characterisation of a rat model of incisional pain. Br J Pharmacol 2004;141:85-91.
21. Yamamoto T, Sakashita Y, Nozaki-Taguchi N. Anti-allodynic effects of oral COX-2 selective inhibitor on postoperative pain in the rat. Can J Anaesth 2000;47:354-60.
22. Ancian P, Lambeau G, Mattei MG, Lazdunski M. The human 180-kDa receptor for secretory phospholipases A2: molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization. J Biol Chem 1995;270:8963-70.
23. Euchenhofer C, Maihofner C, Brune K, et al. Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Neurosci Lett 1998;248:25-8.
24. Mazario J, Gaitan G, Herrero JF. Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. Neuropharmacology 2001;40:937-46.
25. Chandrasekharan NV, Dai H, Roos KL, et al. From the Cover: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci U S A 2002;99:13926-31.